WHO ICTRP trial
Efficacy and safety of Keverprazan in the treatment of refractory reflux…
ChiCTR2400082937 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400082937 |
|---|---|
| Public title | Efficacy and safety of Keverprazan in the treatment of refractory reflux esophagitis |
| Scientific title | Efficacy and safety of Keverprazan in the treatment of refractory reflux esophagitis |
| Primary sponsor | Zhejiang Provincial People’s Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Refractory reflux esophagitis |
| Interventions | treatment group:Keverprazan, 20mg, QD;Maintenance group:Keverprazan, 10mg, QD;Surgical group:Fundoplication |
| Registration date | Apr 11, 2024 |
| Target size | treatment group:20;Maintenance group:10;Surgical group:10 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: